Cardiovascular journal of Africa · 2018
Absolute cardiovascular risk of women using hormonal contraception in Porto-Novo.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sonou Arnaud, Ogoudjobi Mathieu, Adjagba Philippe Mahouna, Houehanou Corine, Aniglé Richard, Codjo Léopold, Hounkponou Murielle, Bognon Rosaire, Assani Salimatou, Amoussou-Guénou Daniel, Houénassi Dèdonougbo Martin
Аннотация
INTRODUCTION: The purpose of this work was to determine the absolute cardiovascular risk (ACVR) of women using hormonal contraception in Porto-Novo.
METHODS: We carried out a descriptive, cross-sectional study, including women at the time of renewal of a hormonal contraceptive method. Blood pressure, fasting venous blood glucose level, body mass index and electrocardiographic left ventricular hypertrophy were studied. The determination of ACVR was dual based on the World Health Organisation (WHO/ISH) and the European Society of Cardiology (ESC/ESH) models.
RESULTS: The mean age of the women was 35.3 ± 8.2 years. Blood pressure and blood glucose levels were high in 24 and 1.5% of cases, respectively. Left ventricular hypertrophy was present in 7.1% of cases. A high ACVR was found in 5.2% of these women, using the ESC/ESH model.
CONCLUSION: The occurrence of women with high ACVR in this group raises the problem of cardiovascular eligibility to the contraceptive method used.
METHODS: We carried out a descriptive, cross-sectional study, including women at the time of renewal of a hormonal contraceptive method. Blood pressure, fasting venous blood glucose level, body mass index and electrocardiographic left ventricular hypertrophy were studied. The determination of ACVR was dual based on the World Health Organisation (WHO/ISH) and the European Society of Cardiology (ESC/ESH) models.
RESULTS: The mean age of the women was 35.3 ± 8.2 years. Blood pressure and blood glucose levels were high in 24 and 1.5% of cases, respectively. Left ventricular hypertrophy was present in 7.1% of cases. A high ACVR was found in 5.2% of these women, using the ESC/ESH model.
CONCLUSION: The occurrence of women with high ACVR in this group raises the problem of cardiovascular eligibility to the contraceptive method used.